SCHEMBL7330272

SCHEMBL7330272

COC(=O)C1=C(C)NC(COC(N)=O)=C(C(=O)OC)C1c1cccc(Cl)c1Cl

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.71
CYP3A4 P08684 4/20 0.71
ABCB11 O95342 4/20 0.71
KDM4E B2RXH2 4/20 0.71
TBXA2R P21731 3/20 0.71
ADRA1A P35348 3/20 0.71
SLC6A3 Q01959 3/20 0.71
CYP1A2 P05177 3/20 0.71
CYP2C19 P33261 3/20 0.71
KMT2A Q03164 3/20 0.71
HIF1A Q16665 3/20 0.71
HSD17B10 Q99714 3/20 0.71
ADORA3 P0DMS8 3/20 0.71
SCN5A Q14524 3/20 0.71
TSHR P16473 3/20 0.71
NR1I2 O75469 3/20 0.71
ALDH1A1 P00352 3/20 0.71
HPGD P15428 3/20 0.71
MAPT P10636 3/20 0.71
MEN1 O00255 2/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7328156 0.96 CYP2C9 (0.78) CYP2C9CYP3A4ABCB11KDM4ETBXA2R
Lemildipine SCHEMBL49443 0.93 CYP2C9 (0.62) CYP2C9CYP3A4ABCB11KDM4ETBXA2R
Lemildipine SCHEMBL29801339 0.93 CYP2C9 (0.62) CYP2C9CYP3A4ABCB11KDM4ETBXA2R
Lemildipine SCHEMBL49442 0.93 CYP2C9 (0.62) CYP2C9CYP3A4ABCB11KDM4ETBXA2R
SCHEMBL7318977 0.93 CYP2C9 (0.68) CYP2C9CYP3A4ABCB11KDM4ETBXA2R
SCHEMBL7320948 0.92 CYP2C9 (0.66) CYP2C9CYP3A4ABCB11KDM4ETBXA2R
SCHEMBL11038359 0.91 CYP2C9 (0.71) CYP2C9CYP3A4ABCB11KDM4ETBXA2R
SCHEMBL7320951 0.91 CYP2C9 (0.62) CYP2C9CYP3A4ABCB11KDM4ETBXA2R
SCHEMBL11357080 0.88 CYP2C9 (0.83) CYP2C9CYP3A4ABCB11KDM4ETBXA2R
SCHEMBL10933416 0.86 CYP2C9 (0.73) CYP2C9CYP3A4ABCB11KDM4ETBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5494923-A Method of ameliorating cerebral circulation BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-02-27 US disclosed
US-5444077-A Ameliorant of cerebral circulation and optical isomer of NB-818, processes for its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-22 US disclosed
EP-0311053-A2 Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-04-12 EP disclosed